Parkinson's Disease Case Study
ClinEdge was contracted to support a sponsor conducting a Device/Drug combination Parkinson’s study, which had randomized 25% of their enrollment goal, more than halfway through the study timeline.
ClinEdge implemented services that provided sites with over a 100% increase in screening activity and a 55% increase in randomizations. Enrollment was met on time and within budget.
Download the case study to learn how these results were achieved.